Get started
Author

Kaan Helvacı

An overlooked indicator of disease activity in ulcerative colitis: Mean platelet volume
2009 · Osman Yüksel, Kaan Helvacı, et al. · Platelets · 235
Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patients
2013 · Ayse Durnali, Necati Alkis, et al. · Medical Oncology · 78
Childhood, Adolescents, and Young Adults (≤25 y) Colorectal Cancer: Study of Anatolian Society of Medical Oncology
2013 · Muhammet A. Kaplan, Abdurrahman Isikdogan, et al. · Journal of Pediatric Hematology/Oncology · 34
Adjuvant Systemic Chemotherapy with or without Bevacizumab in Patients with Resected Liver Metastases from Colorectal Cancer
2012 · Nedim Turan, Mustafa Benekli, et al. · Oncology · 24
Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study.
2012 · A Inal, F T Kos, et al. · PubMed · 20
Endocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors: A Comprehensive Analysis
2025 · Meric Dokmetas, Harun Muglu, et al. · Medicina · 17
PDF
Gemcitabine Alone versus combination of Gemcitabine and Cisplatin for the Treatment of Patients with Locally Advanced and/or Metastatic Pancreatic Carcinoma: A Retrospective Analysis of multicenter study (Anatolian Society of Medical Oncology)
2012 · A. INAL, F. T. KOS, et al. · Neoplasma · 16
PDF
Comparison of clinicopathological and survival features of right and left colon cancers.
2019 · Kaan Helvaci, Emrah Eraslan, et al. · PubMed · 15
Clinicopathological Features in Bilateral Breast Cancer
2012 · Meltem Baykara, Selcuk Cemil Ozturk, et al. · Asian Pacific Journal of Cancer Prevention · 15
Clinical and pathological significance of programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) expression in high grade serous ovarian cancer
2020 · Yılmaz Baş, Nermin Koç, et al. · Translational Oncology · 14
PDF
Multicenter Evaluation of Patients with Cutaneous Malignant Melanoma in Turkey: MELAS Study
2013 · Ozlem Uysal-Sonmez, Ozgur Tanriverdi, et al. · Asian Pacific Journal of Cancer Prevention · 13
PDF
Clinical outcomes and prognostic factors of adult’s Ewing sarcoma family of tumors: single center experience
2016 · Ummugul Uyeturk, Kaan Helvaci, et al. · Współczesna Onkologia · 11
Effects of comorbidities and functional living activities on survival in geriatric breast cancer patients
2014 · Ozlem U. Sonmez, Ulku Y. Arslan, et al. · Współczesna Onkologia · 10
PDF
Detection of Circulating Tumor Cells in Breast Cancer Patients: Prognostic Predictive Role
2013 · Ibrahim Turker, Ummugul Uyeturk, et al. · Asian Pacific Journal of Cancer Prevention · 10
PDF
The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey
2023 · Arif Akyildiz, Deniz Can Guven, et al. · Medicine · 9
Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer
2014 · Nedim Turan, Mustafa Benekli, et al. · Thoracic Cancer · 7
PDF
Prognostic Factors in Operated Stage IIIC, Pathological N3a Breast Cancer Patients
2014 · Ibrahim Turker, Ulku Y. Arslan, et al. · Breast Care · 7
Metformin in diabetic pancreatic cancer patients: Benefit or not—Multicenter experience.
2013 · Onur Esbah, Berna Oksuzoglu, et al. · Journal of Clinical Oncology · 5
Clinicopathological and prognostic significance of PD-L1 expression in colon adenocarcinoma tumor budding
2023 · Yılmaz Baş, Bayram Yılmaz, et al. · Annals of Diagnostic Pathology · 4
Real-world associations of pathological complete response and survival with neoadjuvant pembrolizumab in early TNBC: a Turkish Oncology Group study
2026 · Harun Muğlu, Erdem Sünger, et al. · Scientific Reports · 3
PDF
Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study
2023 · Sabin Goktas Aydin, Engin Eren Kavak, et al. · Biomolecules and Biomedicine · 3
PDF
Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis
2026 · Baris Koksal, Hasan Cagri Yildirim, et al. · Journal of Clinical Medicine · 2
PDF
The Clinical Outcomes and Safety of Sacituzumab Govitecan in Heavily Pretreated Metastatic Triple-Negative and HR+/HER2− Breast Cancer: A Multicenter Observational Study from Turkey
2025 · Harun Muğlu, Kaan Helvacı, et al. · Cancers · 2
PDF
Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study).
2022 · Ahmet Bilici, Omer Fatih Olmez, et al. · Journal of Clinical Oncology · 2
Sequential therapy and prognostic factors in metastatic renal cell carcinoma: single centre experience.
2014 · Onur Esbah, Umut Demirci, et al. · PubMed · 2
Works count: 66
Citation count: 571
H-index: 11
I10-index: 14
Year
Topic
Type